It was very worthwhile being at Neurotech again this year with a number of leads currently being followed-up. I am sure Neurotech will again be high on our agenda in 2020.
- Head Clinical Operations, Neuroscience Trials Australia
I heard praise for your organizational genius from many of the participants who were impressed by the quality of the program, including all of the panelists who were very pleased.
- Director of the Laboratory for Neuromotor Signal Processing, Massachusetts General Hospital; Assistant Professor , Harvard Medical School
I really enjoyed the rare disease panel and had 2 full days of 1:1 partnering which was absolutely priceless for I-corps. I met with VCs and other biotech in the rare disease space - these will help with our Batten disease project. I also found several potential companies that could help fill gaps in our expertise. I would highly recommend this meeting
to small companies that want to learn more about bigger company partnering needs and networking.
- Collaborations Pharmaceuticals, Inc.